GeneDx to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:

• Jefferies Global Healthcare Conference – June 4, 2025
  New York City, New York
  Fireside chat on Wednesday, June 4 at 9:55 a.m. ET

• Goldman Sachs 46th Annual Global Healthcare Conference – June 9, 2025
  Miami Beach, Florida
  Fireside chat on Monday, June 9 at 4:00 p.m. ET

Live and archived webcasts of the presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250521924465/en/

Investor Relations Contact:
[email protected]

Media Contact:
[email protected]

Source: GeneDx

You May Also Be Interested In

• Statement of B&G Foods Regarding the Competition Bureau Challenge of Pending Sale of Green Giant Canada to Nortera
• Mechanics Bancorp Declares Third Quarter 2026 Cash Dividend
• Saba Capital Announces Name Change of the Saba Closed-End Funds ETF to Saba Opportunistically Hedged Closed-End Funds ETF